glp-1 dialysis Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease How glucagon-like peptide 1 receptor

A healthy gut is a healthy you.(1) These statements have not been evaluated by the Food and Drug Administration

Learn more about this transformative advancement in OSA therapy.

A new study published in April sheds light on the concerns of anesthesiologists across the United States related to the perioperative management of patients taking glucagon-like peptide-1 (GLP-1) agonists, a class of drugs now commonly prescribed for both diabetes and cosmetic weight loss

Exclusive Offer for First-Time Mounjaro Users

4 : Build governance and clinical review processes now in anticipation of potential future GLP-1 use in substance use disorder management.